Correlation Between Rongsheng Petrochemical and Innovative Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rongsheng Petrochemical and Innovative Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rongsheng Petrochemical and Innovative Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rongsheng Petrochemical Co and Innovative Medical Management, you can compare the effects of market volatilities on Rongsheng Petrochemical and Innovative Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rongsheng Petrochemical with a short position of Innovative Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rongsheng Petrochemical and Innovative Medical.

Diversification Opportunities for Rongsheng Petrochemical and Innovative Medical

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Rongsheng and Innovative is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Rongsheng Petrochemical Co and Innovative Medical Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovative Medical and Rongsheng Petrochemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rongsheng Petrochemical Co are associated (or correlated) with Innovative Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovative Medical has no effect on the direction of Rongsheng Petrochemical i.e., Rongsheng Petrochemical and Innovative Medical go up and down completely randomly.

Pair Corralation between Rongsheng Petrochemical and Innovative Medical

Assuming the 90 days trading horizon Rongsheng Petrochemical is expected to generate 7.44 times less return on investment than Innovative Medical. But when comparing it to its historical volatility, Rongsheng Petrochemical Co is 2.0 times less risky than Innovative Medical. It trades about 0.06 of its potential returns per unit of risk. Innovative Medical Management is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  626.00  in Innovative Medical Management on September 22, 2024 and sell it today you would earn a total of  476.00  from holding Innovative Medical Management or generate 76.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Rongsheng Petrochemical Co  vs.  Innovative Medical Management

 Performance 
       Timeline  
Rongsheng Petrochemical 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Rongsheng Petrochemical Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Rongsheng Petrochemical may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Innovative Medical 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Rongsheng Petrochemical and Innovative Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rongsheng Petrochemical and Innovative Medical

The main advantage of trading using opposite Rongsheng Petrochemical and Innovative Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rongsheng Petrochemical position performs unexpectedly, Innovative Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovative Medical will offset losses from the drop in Innovative Medical's long position.
The idea behind Rongsheng Petrochemical Co and Innovative Medical Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stocks Directory
Find actively traded stocks across global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years